INOVIO Provides Update on COVID-19 Heterologous Booster Vaccine Candidate, INO-4800PRNewsWire • 10/27/22
INOVIO Reports Positive Interim Phase 1/2 Results for INO-3107 for the Treatment of Recurrent Respiratory PapillomatosisPRNewsWire • 10/13/22
Inovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 24th Annual Global Investment Conference (Transcript)Seeking Alpha • 09/12/22
INOVIO to Present at the H.C. Wainwright 24th Annual Global Investment ConferencePRNewsWire • 08/30/22
Inovio Pharmaceuticals, Inc. (INO) CEO Jacqueline Shea on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/10/22
Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 08/02/22
INOVIO Announces Corporate Reorganization to Reduce Operational Expenses and Focus on Opportunities to Bring the Promise of DNA Medicines to PatientsPRNewsWire • 07/19/22
Inovio Pharmaceuticals, Inc. (INO) CEO Jacqui Shea Present at Jefferies 2022 Global Healthcare Conference (Transcript)Seeking Alpha • 06/08/22